Cartesian Therapeutics (RNAC) Preferred Dividend Payments (2015 - 2026)

Cartesian Therapeutics (RNAC) posted quarterly Preferred Dividend Payments of $2.6 million for Q2 2025, down 37.55% year-over-year from $4.2 million in Q2 2024, and down 37.55% quarter-over-quarter from $4.2 million in Q2 2024.

Cartesian Therapeutics (RNAC) Preferred Dividend Payments (2015 - 2026) Analysis & Trends

Cartesian Therapeutics (RNAC) has reported Preferred Dividend Payments for 4 consecutive years, with $2.6 million the latest figure, recorded in Q2 2025.

  • In Q2 2025, Preferred Dividend Payments fell 37.55% year-over-year to $2.6 million; the TTM figure through Jun 2025 stood at $6.8 million (up 62.45% YoY), while the FY2016 annual figure was $4.6 million, down 37.75% from the prior year.
  • Preferred Dividend Payments fell to $2.6 million in Q2 2025 per RNAC's latest filing, from $4.2 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $4.2 million in Q2 2024 and bottomed at $2.6 million in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Cartesian Therapeutics 265.54 Mn 265.54 Mn - 2.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05 Mn
Jun 30, 2025 2.63 Mn
Jun 30, 2024 4.21 Mn
Jun 30, 2016 2.21 Mn
Mar 31, 2016 2.36 Mn
Dec 31, 2015 2.38 Mn
Sep 30, 2015 1.84 Mn
Jun 30, 2015 1.56 Mn